Pyrantel embonate chewable tablets.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 288
- Publication type:
- Article
Works matching IS 10109609 AND DT 2011 AND VI 25 AND IP 3
Results: 73
1
2
International Nonproprietary Names for Pharmaceutical Substances (INN)
- Published in:
- 2011
- Publication type:
- Journal Article
3
Pandemrix®: restriction in use.
- Published in:
- 2011
- Publication type:
- Journal Article
4
International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 295
- Publication type:
- Article
5
Pyrantel embonate oral suspension.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 291
- Publication type:
- Article
6
2.3 Sulfated ash.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 287
- Publication type:
- Article
7
5.7 Tests for particulate contamination.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 280
- Publication type:
- Article
8
5.6 Extractable volume of parenteral preparations.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 279
- Publication type:
- Article
9
5.3 Disintegration test for tablets and capsules.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 277
- Publication type:
- Article
10
3.3.2 Microbial examination of non sterile products: tests for specified microorganisms.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 265
- Publication type:
- Article
11
3.3.1. Microbiological examination of non-sterile products: microbial enumeration tests.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 255
- Publication type:
- Article
12
3.3 Microbial purity of pharmaceutical preparations.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 252
- Publication type:
- Article
13
Ticagrelor: approved to treat acute coronary syndromes.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 251
- Publication type:
- Article
14
Rivaroxaban approved to reduce risk of blood clots.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 251
- Publication type:
- Article
15
Indacaterol: approved for chronic obstructive pulmonary disease.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 250
- Publication type:
- Article
16
Pandemrix®: restriction in use.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 250
- Publication type:
- Article
17
Artemisinin-based malaria treatment approved.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 250
- Publication type:
- Article
18
Nimesulide-containing medicines: restricted use.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 249
- Publication type:
- Article
19
Addiction to benzodiazepines and codeine: safer use.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 248
- Publication type:
- Article
20
Use of 2011 seasonal influenza vaccines in children.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 247
- Publication type:
- Article
21
Thalidomide: risk of arterial and venous thromboembolism.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 247
- Publication type:
- Article
22
Tamoxifen: CYP2D6 interactions and variable clinical response.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 246
- Publication type:
- Article
23
Rituximab: fatal infusion-related reactions.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 245
- Publication type:
- Article
24
Antipsychotic drugs update: newborns.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 245
- Publication type:
- Article
25
Floseal® hemostatic matrix: misinterpretation of recurrent malignant disease.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 244
- Publication type:
- Article
26
Proton pump inhibitors: hypomagnesemia, hypocalcemia and hypokalemia.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 243
- Publication type:
- Article
27
Pioglitazone: risk of bladder cancer.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 243
- Publication type:
- Article
28
Dexrazoxane: contraindicated in children and adolescents.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 242
- Publication type:
- Article
29
Regulatory Support.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 240
- Publication type:
- Article
30
WHO Prequalification of Medicines Programme.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 231
- By:
- Publication type:
- Article
31
Specifications for pharmaceutical preparations.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 229
- Publication type:
- Article
32
Pharmacopoeial Discussion Group: update.
- Published in:
- 2011
- Publication type:
- Proceeding
33
Chewable tablets: time to reassess a 'neglected' dosage form?
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 223
- Publication type:
- Article
34
Recovery of solvents in API manufacturing.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 221
- Publication type:
- Article
35
Pneumovax 23®: injection site reactions.
- Published in:
- 2011
- Publication type:
- Journal Article
36
International Nonproprietary Names for Pharmaceutical Substances (INN): Proposed International Nonproprietary Names: List 105.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 151
- Publication type:
- Article
37
Paediatric retinol oral solution.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 147
- Publication type:
- Article
38
Revision of monograph on tablets.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 139
- Publication type:
- Article
39
Revision of monograph on capsules.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 135
- Publication type:
- Article
40
Artesunate instead of quinine saves lives.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 134
- Publication type:
- Article
41
World medicines situation.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 133
- Publication type:
- Article
42
List of medicines to save mothers and children.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 133
- Publication type:
- Article
43
Policy guidelines on controlled substances.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 132
- Publication type:
- Article
44
Selection and use of medicines.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 131
- Publication type:
- Article
45
ATC/DDD Classification (final).
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 128
- Publication type:
- Article
46
ATC/DDD Classification (temporary).
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 126
- Publication type:
- Article
47
Erythropoietin: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 125
- Publication type:
- Article
48
Lumiracoxib: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 125
- Publication type:
- Article
49
Naproxcinod: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 124
- Publication type:
- Article
50
Linagliptin approved for type 2 diabetes.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 3, p. 124
- Publication type:
- Article